evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1
Pay in 4 interest-free payments of $6.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://cdn.sanity.io/images/0vv8moc6/drugtopics/95e97d281e5924cde2da30014f9dab359d32abfa-7200x3600.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://images.ctfassets.net/1clcztbbevpp/32JWkEPaMfea2iBEyYZp3W/dd812edf3ff0e6abb685af17cfa3c1f2/injectable-weight-loss.jpg?w=1200&q=60)
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://mmassets.universaldrugstore.com/wp-content/uploads/generic-ozempic-1-424x478.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://pandameds.com/wp-content/uploads/2025/12/GLP-1-Receptor-Agonists.webp)
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://leanmd.com/wp-content/uploads/2026/06/ChatGPT-Image-Jun-3-2026-11_00_12-AM.png)
![evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://www.rivasweightloss.com/wp-content/uploads/2024/05/glp-1-banner.png)






















